Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus

被引:29
|
作者
Helminen, Olli [1 ,2 ]
Pokka, Tytti [1 ,2 ]
Tossavainen, Paivi [1 ,2 ]
Ilonen, Jorma [3 ,4 ]
Knip, Mikael [5 ,6 ,7 ,8 ,9 ]
Veijola, Riitta [1 ,2 ]
机构
[1] Oulu Univ Hosp, Med Res Ctr, PEDEGO Res Unit, Dept Pediat, Oulu, Finland
[2] Univ Oulu, Oulu, Finland
[3] Univ Turku, Immunogenet Lab, Turku, Finland
[4] Turku Univ Hosp, Turku, Finland
[5] Tampere Univ Hosp, Tampere Ctr Child Hlth Res, Tampere, Finland
[6] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[7] Helsinki Univ Hosp, Helsinki, Finland
[8] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland
[9] Folkhalsan Res Ctr, Helsinki, Finland
基金
芬兰科学院;
关键词
Type 1 diabetes mellitus; Autoantibodies; Glucose intolerance; Self-monitoring; Blood-glucose; Prediabetes;
D O I
10.1016/j.diabres.2016.07.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Continuous glucose monitoring (CGM) parameters, self-monitored blood glucose (SMBG), HbA1c and oral glucose tolerance test (OGTT) were studied during preclinical type 1 diabetes mellitus. Methods: Ten asymptomatic children with multiple (>= 2) islet autoantibodies (cases) and 10 age and sex-matched autoantibody-negative controls from the Type 1 Diabetes Prediction and Prevention (DIPP) Study were invited to 7-day CGM with Dexcom G4 Platinum Sensor. HbA1c and two daily SMBG values (morning and evening) were analyzed. Five-point OGTTs were performed and carbohydrate intake was assessed by food records. The matched pairs were compared with the paired sample t-test. Results: The cases showed higher mean values and higher variation in glucose levels during CGM compared to the controls. The time spent >= 7.8 mmol/l was 5.8% in the cases compared to 0.4% in the controls (p = 0.040). Postprandial CGM values were similar except after the dinner (6.6 mmol/l in cases vs. 6.1 mmol/l in controls; p = 0.023). When analyzing the SMBG values higher mean level, higher evening levels, as well as higher variation were observed in the cases when compared to the controls. HbA1c was significantly higher in the cases [5.7% (39 mmol/mol) vs. 5.3% (34 mmol/mol); p = 0.045]. No differences were observed in glucose or C-peptide levels during OGTT. Daily carbohydrate intake was slightly higher in the cases (254.2 g vs. 217.7 g; p = 0.034). Conclusions: Glucose levels measured by CGM and SMBG are useful indicators of dysglycemia during preclinical type 1 diabetes mellitus. Increased evening glucose values seem to be common in children with preclinical type 1 diabetes mellitus. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条
  • [1] The interrelationship of HbA1c and real-time continuous glucose monitoring in children with type 1 diabetes
    Ferenci, Tamas
    Koerner, Anna
    Kovacs, Levente
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : 38 - 44
  • [2] How the continuous glucose monitoring system can contribute to HbA1c interpretation in type 1 diabetes mellitus?
    Punales, Maraa K. C.
    Geremia, Cesar
    Mondadori, Paula
    Pickler, Marilisa
    Fornari, Adriana
    Tschiedel, Balduino
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (02) : 299 - 306
  • [3] HbA1C, Glucose Variability and Hypoglycemia Risk in Patients With Type 1 Diabetes Mellitus
    Guelho, Daniela F.
    Barros, Luisa
    Baptista, Carla
    Paiva, Isabel
    Gouveia, Sofia
    Saraiva, Joana
    Moreno, Carolina
    Ruas, Luisa
    Carvalheiro, Manuela
    Carrilho, Francisco
    DIABETES, 2013, 62 : A223 - A223
  • [4] The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)
    Sartore, Giovanni
    Chilelli, Nino Cristiano
    Burlina, Silvia
    Di Stefano, Paola
    Piarulli, Francesco
    Fedele, Domenico
    Mosca, Andrea
    Lapolla, Annunziata
    ACTA DIABETOLOGICA, 2012, 49 : S153 - S160
  • [5] The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)
    Giovanni Sartore
    Nino Cristiano Chilelli
    Silvia Burlina
    Paola Di Stefano
    Francesco Piarulli
    Domenico Fedele
    Andrea Mosca
    Annunziata Lapolla
    Acta Diabetologica, 2012, 49 : 153 - 160
  • [6] Flash glucose monitoring improves HbA1c in people with type 1 diabetes
    Harte, R.
    Connelly, P.
    Drummond, R.
    Carty, D.
    Osborne, L.
    Cleland, S.
    Kennon, B.
    Hopkinson, H.
    Smith, C.
    Boyle, J. G.
    DIABETIC MEDICINE, 2020, 37 : 147 - 147
  • [7] Determination of Glucose-Independent Racial Disparity in HbA1c for Youth With Type 1 Diabetes in the Era of Continuous Glucose Monitoring
    Christakis, Nicholas J.
    Gioe, Marcella
    Gomez, Ricardo
    Felipe, Dania
    Soros, Arlette
    Mccarter, Robert
    Chalew, Stuart
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2025, 19 (01): : 72 - 79
  • [8] Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus
    Kurozumi, Akira
    Okada, Yosuke
    Mita, Tomoya
    Wakasugi, Satomi
    Katakami, Naoto
    Yoshii, Hidenori
    Kanda, Kazuko
    Nishida, Keiko
    Mine, Shinichiro
    Tanaka, Yoshiya
    Gosho, Masahiko
    Shimomura, Iichiro
    Watada, Hirotaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [9] Accuracy of glucose sensor estimate of HbA1c in children with type 1 diabetes
    Ehtisham, Sarah
    Adhami, Sara
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 87 - 87
  • [10] Introduction of continuous glucose monitoring (CGM) is a key factor in decreasing HbA1c in war refugee children with type 1 diabetes
    Neuman, V.
    Vavra, D.
    Drnkova, L.
    Pruhova, S.
    Plachy, L.
    Kolouskova, S.
    Obermannova, B.
    Amaratunga, S. A.
    Konecna, P.
    Vyzralkova, J.
    Venhacova, P.
    Pomahacova, R.
    Paterova, P.
    Stichova, L.
    Skvor, J.
    Kocourkova, K.
    Romanova, M.
    Vosahlo, J.
    Strnadel, J.
    Polockova, K.
    Neumann, D.
    Slavenko, M.
    Sumnik, Z.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 208